Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMND
CMND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMND News
Clearmind Completes Dosing for Phase I/II Trial of CMND-100
4d ago
Newsfilter
Biotech Stocks Show Significant Pre-Market Movements
Jun 05 2026
NASDAQ.COM
Clearmind Medicine to Host Webinar on MEAI Clinical Data
Jun 05 2026
Newsfilter
Replimune Receives FDA Support for BLA Resubmission
Jun 01 2026
NASDAQ.COM
Clearmind Secures Patent and Clinical Approval for Alcohol Use Disorder Treatment
May 29 2026
stocktwits
Clearmind Files Japanese Patent Application, Strengthening Antidepressant Development
May 29 2026
Newsfilter
Multiple Companies See Significant Stock Price Gains
May 27 2026
NASDAQ.COM
Clearmind Medicine Receives Approval for Phase I/II Clinical Trial
May 26 2026
Newsfilter
Clearmind Medicine to Execute 1-for-10 Reverse Stock Split
May 19 2026
seekingalpha
Clearmind Announces 1-for-10 Reverse Stock Split
May 19 2026
Newsfilter
Clearmind Medicine Engages in Federal Policy Summit
May 15 2026
Newsfilter
Clearmind's Positive Clinical Trial Results May Support Breakthrough Therapy Designation
Apr 27 2026
Newsfilter
CLEARMIND MEDICINE INC - HAS NOT APPLIED FOR OR BEEN GRANTED FDA BREAKTHROUGH THERAPY DESIGNATION FOR MEAI
Apr 27 2026
moomoo
Clearmind Medicine Reports Positive Clinical Trial Results and Regulatory Support
Apr 21 2026
NASDAQ.COM
Trump Signs Executive Order to Accelerate Psychedelic Research
Apr 20 2026
stocktwits
Clearmind's Drug Clinical Trial Achieves Success
Apr 20 2026
Newsfilter
Show More News
